441 Results

People

  1. Hudis
    Hudis
  2. Bajorin
    Bajorin
  3. Seidman
    Seidman
  4. Zelenetz
    Zelenetz
  5. Aghajanian
    Aghajanian
  6. Fornier
    Fornier
  7. Norton
    Norton
  8. Tallman
    Tallman
  9. Hensley
    Hensley
  10. Moskowitz
    Moskowitz

Groups

  1. Department of Medicine (326)
  2. Solid Tumor Oncology Division (204)
  3. Hematologic Malignancies, Division of (144)
  4. Center for Hematologic Malignancies (128)
  5. Survivorship Research (93)
  6. Breast Medicine Service (63)
  7. Epidemiology and Biostatistics (59)
  8. Biostatistics Service (55)
  9. Lymphoma (54)
  10. Adult Leukemia (47)
  1. "febrile neutropenia"
Formats
  1. Journal Article (414)
  2. Review (15)
  3. Research Letter (7)
  4. Editorial (3)
  5. Conference Paper (1)
  6. Correspondence (1)
Groups
  1. Department of Medicine (326)
  2. Solid Tumor Oncology Division (204)
  3. Hematologic Malignancies, Division of (144)
  4. Center for Hematologic Malignancies (128)
  5. Survivorship Research (93)
  6. Breast Medicine Service (63)

More Groups

People
  1. Clifford Hudis (30)
  2. Dean Bajorin (21)
  3. Andrew Seidman (18)
  4. Andrew Zelenetz (17)
  5. Martin Tallman (17)
  6. Larry Norton (16)

More People

Years
  1. 2025 (10)
  2. 2024 (24)
  3. 2023 (26)
  4. 2022 (15)
  5. 2021 (11)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (52)
  2. Cancer (28)
  3. Blood (22)
  4. Annals of Oncology (18)
  5. Clinical Cancer Research (17)
  6. Leukemia and Lymphoma (15)

More Publications

Publishers
  1. Elsevier Inc. (54)
  2. American Society of Clinical Oncology (53)
  3. Wiley Blackwell (35)
  4. Springer (34)
  5. American Society of Hematology (30)
  6. Oxford University Press (30)

More Publishers

Results (441)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma
    Journal Article

    Lauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies
    Journal Article

    Lopez, J. S.; Milhem, M.; Butler, M. O.; Thistlethwaite, F.; Van Tine, B. A.; D'Angelo, S. P.; Johnson, M. L.; Sato, T.; Arkenau, H. T.; Edukulla, R.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Understanding oncologic emergencies and related emergency department visits and hospitalizations: A systematic review
    Journal Article

    Yilmaz, S.; Aryal, K.; King, J.; Bischof, J. J.; Hong, A. S.; Wood, N.; Gould Rothberg, B. E.; Hudson, M. F.; Heinert, S. W.; Wattana, M. K.; more...
    BMC Emergency Medicine (2025)

    Fulltext@MSK | Save
  • Methodologic approach to defining comorbidities in a cohort of patients with cancer: An example in the optimal breast cancer chemotherapy dosing study
    Journal Article

    Wang, P.; O'Connell, K.; Bhimani, J.; Blinder, V.; Burganowski, R.; Ergas, I. J.; Gallagher, G. B.; Griggs, J. J.; Heon, N.; Kolevska, T.; more...
    JCO Clinical Cancer Informatics (2025)

    Fulltext@MSK | Save
  • SWOG S1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers
    Journal Article

    Shroff, R. T.; King, G.; Colby, S.; Scott, A. J.; Borad, M. J.; Goff, L.; Matin, K.; Mahipal, A.; Kalyan, A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Journal Article

    Shadman, M.; Salkar, M.; Srivastava, B.; Karve, S.; Emond, B.; Gogna, P.; Manceur, A. M.; Lafeuille, M. H.; Rava, A.; Sun, H.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): A single-arm, open-label, phase 1, dose-escalation study
    Journal Article

    Iyer, S. P.; Sica, R. A.; Ho, P. J.; Prica, A.; Zain, J.; Foss, F. M.; Hu, B.; Beitinjaneh, A.; Weng, W. K.; Kim, Y. H.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: A multicentre, single-arm, phase 2 trial
    Journal Article

    Heinzerling, J. H.; Mileham, K. F.; Robinson, M. M.; Symanowski, J. T.; Induru, R. R.; Brouse, G. M.; Corso, C. D.; Prabhu, R. S.; Haggstrom, D. E.; Moeller, B. J.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: A phase 1, first-in-human trial
    Journal Article

    Ghobadi, A.; Bachanova, V.; Patel, K.; Park, J. H.; Flinn, I.; Riedell, P. A.; Bachier, C.; Diefenbach, C. S.; Wong, C.; Bickers, C.; more...
    Lancet (2025)

    Fulltext@MSK | Save
  • A first-in-human study of cinrebafusp alfa, a HER2/4-1BB bispecific molecule, in patients with HER2-positive advanced solid malignancies
    Journal Article

    Piha-Paul, S.; Olwill, S. A.; Hamilton, E.; Tolcher, A.; Pohlmann, P.; Liu, S. V.; Wurzenberger, C.; Hasenkamp, L. C.; Hansbauer, E. M.; Shroff, R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save